Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1017 | 1017 | 1084 | 1073 | 1224 | 1336 |
Fund Return | 1.7% | 1.7% | 8.44% | 2.37% | 4.12% | 2.94% |
Place in category | 2013 | 2013 | 1696 | 1347 | 1295 | 572 |
% in Category | 93 | 93 | 85 | 75 | 88 | 63 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Robeco BP US Premium Equities F $ | 5.21B | 8.63 | 9.51 | 9.42 | ||
Robeco BP US Premium Equities I $ | 5.21B | 4.06 | 10.16 | 9.34 | ||
Robeco BP US Premium Equities K $ | 5.21B | 4.06 | 10.16 | 9.34 | ||
LU0226953718 | 5.21B | -1.43 | 12.22 | 7.39 | ||
R Global Consumer Trends Equities M | 4.12B | 8.07 | -2.62 | 8.95 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFSM European Value Fund A1 USD | 2.68B | -1.29 | 1.47 | 4.99 | ||
MFSM European Value Fund I1 USD | 2.68B | -1.14 | 2.48 | 6.03 | ||
MFSM European Value Fund N1 USD | 2.68B | -1.35 | 0.97 | 4.46 | ||
MFSM European Value Fund W1 USD | 2.68B | -1.16 | 2.23 | 5.78 | ||
Europe Equity Plus Fund A perf acc | 1.87B | 10.19 | 8.83 | 4.80 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 3.56 | 883.2 | +0.07% | |
Unilever | GB00B10RZP78 | 2.82 | 49.17 | +0.22% | |
Novartis | CH0012005267 | 2.81 | 90.54 | +0.85% | |
TotalEnergies SE | FR0000120271 | 2.78 | 67.23 | +0.24% | |
Nestle | CH0038863350 | 2.75 | 94.20 | +2.21% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review